Related Experiment Video
Updated: Jul 19, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Ensuring a safe and adequate blood supply during the COVID-19 pandemic: the Moroccan National Blood Center experience
Sabah Bouhou1, Mohammed Benajiba1
1National Center for Blood Transfusion and Hematology, Rabat, Morocco.
Insights
The COVID-19 pandemic significantly impacts blood donation and transfusion services. The National Blood Centre of Morocco adapted quickly, implementing measures to ensure blood product safety and availability during the health crisis.
Area of Science:
- Transfusion Medicine
- Infectious Diseases
- Public Health
Background:
- The emergence of SARS-CoV-2 (COVID-19) in late 2019 has had global health implications.
- International scientific bodies recognize the pandemic's significant impact on blood donation and transfusion activities.
- Ensuring the availability and safety of blood products is critical during health crises.
Purpose of the Study:
- To highlight the impact of the COVID-19 pandemic on blood transfusion services.
- To describe the adaptive measures implemented by the National Blood Centre of Morocco (MNBC).
- To emphasize the importance of managing transfusion center operations during a pandemic.
Main Methods:
- Review of the impact of the COVID-19 pandemic on blood donation and transfusion.
- Description of measures implemented by the MNBC.
- Adaptation of protocols based on evolving national and international health data.
Main Results:
- The COVID-19 pandemic poses challenges to blood product availability and safety.
- The MNBC demonstrated rapid reactivity and adaptability in response to the crisis.
- Continuous updates of implemented measures ensured alignment with current scientific and health authority guidance.
Conclusions:
- Effective management strategies are essential for transfusion centers during pandemics.
- Proactive and adaptive measures by national blood centers are crucial for maintaining blood supply.
- The MNBC's response serves as a model for managing transfusion activities during the COVID-19 health crisis.
Abstract:
At the end of 2019, a new coronavirus was identified in people living in the city of Wuhan in China. Since the appearance of the first cases in Wuhan, the SARS-CoV-2 epidemic has spread to the international scale. The COVID-19 pandemic is considered by international scientific societies to have an impact on blood donation and transfusion activities. Efforts must be made at the level of the transfusion centres to ensure proper management of the impact of this health crisis on the availability and the safety of blood products. The National Blood Centre of Morocco (MNBC) has demonstrated a great reactivity and a great adaptability since the beginning of the epidemic and has implemented several measures to face this health crisis. These measures have been updated taking into account the updating of data from national health authorities and international scientific societies concerning this new virus.
Related Concept Videos
Blood Flow
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Errors occurring during blood pressure monitoring
Several factors...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

